ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

UNCY Unicycive Therapeutics Inc

1.10
-0.02 (-1.79%)
Pre Market
Last Updated: 22:22:20
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Unicycive Therapeutics Inc UNCY NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -1.79% 1.10 22:22:20
Open Price Low Price High Price Close Price Previous Close
1.12
more quote information »

Recent News

Date Time Source Heading
10/4/202421:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
29/3/202407:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
25/3/202422:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
14/3/202422:03GLOBEUnicycive Announces $50 Million Private Placement
13/3/202422:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
08/3/202408:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
04/3/202423:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
22/2/202408:06EDGAR2Form 8-K - Current report
14/2/202423:03GLOBEUnicycive Therapeutics to Present Two Posters on..
29/1/202423:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
23/1/202423:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
23/1/202408:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202323:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
09/12/202308:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/11/202323:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
15/11/202308:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202308:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
24/10/202302:12EDGAR2Form 8-K - Current report
23/10/202322:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
26/9/202306:05EDGAR2Form 8-K - Current report
08/9/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202306:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202323:16EDGAR2Form 8-K - Current report
06/9/202321:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
01/9/202306:16EDGAR2Form 8-K - Current report
31/8/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202321:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
15/8/202307:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
15/8/202307:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202306:15EDGAR2Form 8-K - Current report
26/7/202320:05EDGAR2Form 8-K - Current report
20/7/202321:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
18/7/202321:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
15/7/202306:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/7/202309:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202307:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..
16/6/202321:38GLOBEUnicycive to Participate in the Healthcare Virtual..
16/5/202322:29GLOBEUnicycive Announces First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock